These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11771624)

  • 1. Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models.
    Gould R; Abramson I; Galasko D; Salmon D
    J Int Neuropsychol Soc; 2001 Nov; 7(7):813-24. PubMed ID: 11771624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring cognitive change in a cohort of patients with Alzheimer's disease.
    Galasko DR; Gould RL; Abramson IS; Salmon DP
    Stat Med; 2000 Jun 15-30; 19(11-12):1421-32. PubMed ID: 10844707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to calculate an MMSE score from a MODA score (and vice versa) in patients with Alzheimer's disease.
    Cazzaniga R; Francescani A; Saetti C; Spinnler H
    Neurol Sci; 2003 Nov; 24(4):261-7. PubMed ID: 14658044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
    Lucchi E; Minicuci N; Magnifico F; Mondini S; Calza A; Avanzi S; Villani D; Bellelli G; Trabucchi M
    Arch Gerontol Geriatr Suppl; 2004; (9):253-63. PubMed ID: 15207422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a 6 item cognitive impairment test with a view to primary care usage.
    Brooke P; Bullock R
    Int J Geriatr Psychiatry; 1999 Nov; 14(11):936-40. PubMed ID: 10556864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease.
    Levine AJ; Battista M
    Arch Clin Neuropsychol; 2004 Sep; 19(6):769-78. PubMed ID: 15288330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Ala TA; Hughes LF; Kyrouac GA; Ghobrial MW; Elble RJ
    Int J Geriatr Psychiatry; 2002 Jun; 17(6):503-9. PubMed ID: 12112173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the diagnostic accuracy of the Cognitive Performance Scale (Minimum Data Set) and the Mini-Mental State Exam for the detection of cognitive impairment in nursing home residents.
    Paquay L; De Lepeleire J; Schoenmakers B; Ylieff M; Fontaine O; Buntinx F
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):286-93. PubMed ID: 17022109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
    Miller JM; Pliskin NH
    Int J Neurosci; 2006 May; 116(5):613-27. PubMed ID: 16644521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Telephone Interview for Cognitive Status (TICS) in Japanese.
    Konagaya Y; Washimi Y; Hattori H; Takeda A; Watanabe T; Ohta T
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):695-700. PubMed ID: 17431929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological assesment of psychogeriatric patients with limited education.
    Marcopulos BA; Gripshover DL; Broshek DK; McLain CA; Brashear HR
    Clin Neuropsychol; 1999 May; 13(2):147-56. PubMed ID: 10949156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.
    Sparks DL; Sabbagh MN; Connor DJ; Lopez J; Launer LJ; Browne P; Wasser D; Johnson-Traver S; Lochhead J; Ziolwolski C
    Arch Neurol; 2005 May; 62(5):753-7. PubMed ID: 15883262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.